Karan Johar recently sold a 50% stake in Dharma Productions to Adar Poonawalla, CEO of Serum Institute, with an investment of Rs 1000 crore. In his first interview post-deal, Karan humorously joked about renaming the company to 'Kabhi Khushi Kabhie Serum' and 'Pharma Productions,

Johar explained that the primary reason behind the partnership was to take Dharma to the next level, where they could fund their own projects without outside support. He said that he wants to ‘chase’ the mid-budget films because that’s where the bigger profits lie.

Just as when everyone was wondering about the reason behind Adar Poonawalla's acquisition of Dharma Productions, Karan Johar seems to have just revealed it

After selling a 50 per cent stake in Dharma Productions to Serum Institute’s Adar Poonawalla, Karan Johar quipped that he is planning to rebrand his company. At the CNBC-TV18 Global Leadership Summit,